Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Jul 16, 2008 by Edgar Snyder

Bone-Building Drugs Can Lead to Weaker Bones

Fosamax

Osteoporosis drugs, while intended to make bones stronger, have been found to lead to weaker bones in some patients. Case reports have shown that after long-term use of the medications, certain patients experienced leg fractures and jaw bone deterioration.

The fractures affected the upper thighbone after little or no trauma to the area and, according to reports, affected patients who used the osteoporosis drug Fosamax for five years or more. A study published in the Journal of Orthopaedic Trauma revealed that 19 out of 20 patients with the thigh fractures had used Fosamax for an average of 6.9 years. Osteonecrosis of the jaw, an illness in which a patient's jawbone rots and dies, is another dangerous side effect believed to be caused by bisphosphonates, or bone-building drugs.

Merck, the maker of Fosamax, is investigating the fracture cases to determine whether or not they are more common in drug users. Merck's executive director for clinical research, Arthur Santora, said that while the fractures led to about 5 or 6 percent of all broken hips, drugs like Fosamax decreased the threat of hip fractures for the other 95 percent of patients.

Source: "Drugs to Build Bones May Weaken Them." New York Times. July 15, 2008.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 30, 2016
September Mocktail: Apple Pie Punch
Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Tweet